HR job title
- Professor
- Contact Info
Palakurthi, Srinath Professor
Positions
- Overview
- Publications
- Research
- Teaching
- Background
- Contact
- Other
- View All
Overview
Publications
selected publications
-
academicarticle
-
Srivatsa Palakurthi, S., Bharat Charbe, N., Recalde Phillips, S. Y., Alge, D. L., Lu, D., & Palakurthi, S.
(2023).
Development of optimal in vitro release and permeation testing method for rectal suppositories. 640, 123042-123042.
-
Charbe, N. B., Tambuwala, M., Palakurthi, S. S., Warokar, A., Hromi-Jahjefendi, A., Bakshi, H., ... Palakurthi, S.
(2023).
Biomedical applications of three-dimensional bioprinted craniofacial tissue engineering. Bioengineering and Translational Medicine.
8(1), e10333.
-
Renukuntla, J., Palakurthi, S. S., Bolla, P. K., Clark, B. A., Boddu, S., Manda, P., ... Palakurthi, S.
(2022).
Advances in in-vitro bioequivalence testing methods for complex ophthalmic generic products. International Journal of Pharmaceutics.
627, 122209-122209.
-
Venkata, P. P., Chen, Y., Alejo, S., He, Y. i., Palacios, B. E., Loeffel, I., ... Sareddy, G. R.
(2022).
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. Cancer Letters.
524, 219-231.
-
Khare, T., Palakurthi, S. S., Shah, B. M., Palakurthi, S., & Khare, S.
(2020).
Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences.
21(11), 3956-3956.
-
Shah, B. M., Palakurthi, S. S., Khare, T., Khare, S., & Palakurthi, S.
(2020).
Natural proteins and polysaccharides in the development of micro/nano delivery systems for the treatment of inflammatory bowel disease. International Journal of Biological Macromolecules.
165(Pt A), 722-737.
-
Vaidya, B., Shukla, S. K., Kolluru, S., Huen, M., Mulla, N., Mehra, N., ... Gupta, V.
(2019).
Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability. Carbohydrate Polymers.
204, 68-77.
-
Mehra, N. K., Tekmal, R. R., & Palakurthi, S.
(2018).
Development and Evaluation of Talazoparib Nanoemulsion for Systemic Therapy of BRCA1-mutant Cancer. Anticancer Research: international journal of cancer research and treatment.
38(8), 4493-4503.
-
Hidau, M. K., Kolluru, S., & Palakurthi, S.
(2018).
Development and validation of a high-performance liquid chromatography method for the quantification of talazoparib in rat plasma: Application to plasma protein binding studies. Biomedical Chromatography.
32(2), e4046-e4046.
-
Palakurthi, S., Kolluru, S., Mehra, N., & Hidau, M.
(2017).
Cyclodextrin Complexation of Meclizine Hydrochloride and its Influence on the Solubility for its Repurposing. Drug Delivery Letters.
7(1), 54-61.
-
Wei, Z., Maganti, M., Martinez, B., Vangara, K. K., Palakurthi, S., Luo, Z., ... Liu, J.
(2016).
Biological study of metal-organic frameworks towards human ovarian cancer cell lines. Canadian Journal of Chemistry.
94(4), 380-385.
-
Mehra, N. K., & Palakurthi, S.
(2016).
Interactions between carbon nanotubes and bioactives: a drug delivery perspective. Drug Discovery Today.
21(4), 585-597.
-
Yellepeddi, V. K., & Palakurthi, S.
(2016).
Recent Advances in Topical Ocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics.
32(2), 67-82.
-
Mehra, N. K., Cai, D., Kuo, L., Hein, T., & Palakurthi, S.
(2016).
Safety and toxicity of nanomaterials for ocular drug delivery applications. Nanotoxicology.
10(7), 836-860.
-
Palakurthi, S.
(2015).
Challenges in SN38 drug delivery: current success and future directions. Expert Opinion on Drug Delivery.
12(12), 1911-1921.
-
Vangara, K. K., Ali, H. I., Lu, D., Liu, J. L., Kolluru, S., & Palakurthi, S.
(2014).
SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer. AAPS PharmSciTech.
15(2), 472-482.
-
Paliwal, R., Babu, R. J., & Palakurthi, S.
(2014).
Nanomedicine scale-up technologies: feasibilities and challenges. AAPS PharmSciTech.
15(6), 1527-1534.
-
Mishra, M. N., Vangara, K. K., & Palakurthi, S.
(2014).
Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11. Anticancer Research: international journal of cancer research and treatment.
34(11), 6345-6351.
-
Paliwal, R., & Palakurthi, S.
(2014).
Zein in controlled drug delivery and tissue engineering. Journal of Controlled Release.
189, 108-122.
-
Yellepeddi, V. K., Vangara, K. K., & Palakurthi, S.
(2013).
Poly(amido)amine (PAMAM) dendrimer-cisplatin complexes for chemotherapy of cisplatin-resistant ovarian cancer cells. Journal of Nanoparticle Research.
15(9), 1897.
-
Vangara, K. K., Liu, J. L., & Palakurthi, S.
(2013).
Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Research: international journal of cancer research and treatment.
33(6), 2425-2434.
-
Kumar, A., & Palakurthi, S.
(2013).
P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy. Drug Delivery Letters.
3(3), 165-174.
-
Yellepeddi, V. K., & Vangara, K. K.
(2013).
In vivo Efficacy of PAMAM-Dendrimer-Cisplatin Complexes in SKOV-3 Xenografted Balb/C Nude Mice. Journal of Biotechnology and Biomaterials.
2013.
-
Sethi, R., Manchanda, S., Perepu, R., Kumar, A., Garcia, C., Kennedy, R. H., Palakurthi, S., & Dostal, D.
(2012).
Differential expression of caveolin-1 and caveolin-3: potential marker for cardiac toxicity subsequent to chronic ozone inhalation. MOLECULAR AND CELLULAR BIOCHEMISTRY.
369(1-2), 9-15.
-
Yellepeddi, V. K., Vangara, K. K., Kumar, A., & Palakurthi, S.
(2012).
Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells. Anticancer Research: international journal of cancer research and treatment.
32(9), 3651-3658.
-
Palakurthi, S., Yellepeddi, V. K., & Vangara, K. K.
(2012).
Recent trends in cancer drug resistance reversal strategies using nanoparticles. Expert Opinion on Drug Delivery.
9(3), 287-301.
-
Kumar, A., Yellepeddi, V. K., Vangara, K. K., Strychar, K. B., & Palakurthi, S.
(2011).
Mechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residues. Journal of Drug Targeting.
19(9), 770-780.
-
Yellepeddi, V. K., Kumar, A., Maher, D. M., Chauhan, S. C., Vangara, K. K., & Palakurthi, S.
(2011).
Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT. Anticancer Research: international journal of cancer research and treatment.
31(3), 897-906.
-
Kumar, A., Yellepeddi, V. K., Davies, G. E., Strychar, K. B., & Palakurthi, S.
(2010).
Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues. International Journal of Pharmaceutics.
392(1-2), 294-303.
-
Yellepeddi, V. K., Kumar, A., & Palakurthi, S
(2009).
Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro. Anticancer Research: international journal of cancer research and treatment.
29(8), 2933-2943.
-
Zhao, Y., Seefeldt, T., Chen, W., Carlson, L., Stoebner, A., Hanson, S., ... Guan, X.
(2009).
Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation. Free Radical Biology and Medicine.
47(2), 176-183.
-
Yellepeddi, V. K., Kumar, A., & Palakurthi, S.
(2009).
Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications. Expert Opinion on Drug Delivery.
6(8), 835-850.
-
Palakurthi, S., Wilson, J., McQuarrie, S. A., Suresh, M. R., Mercer, J. R., & Miller, G. G.
(2008).
Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo. In Vivo: international journal of experimental and clinical pathophysiology and drug research.
22(3), 321-326.
-
Pisal, D. S., Yellepeddi, V. K., Kumar, A., Kaushik, R. S., Hildreth, M. B., Guan, X., & Palakurthi, S.
(2008).
Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers. International Journal of Pharmaceutics.
350(1-2), 113-121.
-
Pisal, D. S., Yellepeddi, V. K., Kumar, A., & Palakurthi, S.
(2008).
Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers. Drug Delivery.
15(8), 515-522.
-
Palakurthi, S., Mcquarrie, S. A., & Suresh, M. R.
(2007).
Screening of 14C-polyamines in the AT3B-1 rat prostate tumor model: the search for a new PET prostate imaging agent. In Vivo: international journal of experimental and clinical pathophysiology and drug research.
21(5), 823-828.
-
Palakurthi, S., Vyas, S. P., & Diwan, P. V.
(2005).
Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. International Journal of Pharmaceutics.
290(1-2), 55-62.
-
Srinath, P., Rao, P. N., Knaus, E. E., & Suresh, M. R.
(2003).
Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation. 23(5A), 3923-3928.
-
Srinath, P., McQuarrie, S. A., & Suresh, M. R.
(2002).
Comparative uptake of polyamines by prostate and non-prostate cancer cell lines. Nuclear Medicine and Biology.
29(4), 497-503.
-
Palakurthi, S., Govardhanachary, M., Vyas, S. P., & Diwan, P. V.
(2000).
Biodistribution of liposomes of terbutaline sulfate in guinea pigs. 26(10), 1099-1105.
-
Srinath, P., Chary, M. G., Vyas, S. P., & Diwan, P. V.
(2000).
Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study. Pharmaceutica acta Helvetiae.
74(4), 399-404.
-
Srinath, P., Vyas, S. P., & Diwan, P. V.
(2000).
Preparation and pharmacodynamic evaluation of liposomes of indomethacin. 26(3), 313-321.
-
SRINATH, P., VYAS, S. P., & DIWAN, P. V.
(1999).
Effect of Lipid Composition of Liposomes on Biodisposition of Indomethacin in Arthritic Rats. Journal of Pharmacy and Pharmacology.
5(5), 339-344.
-
Srinath, P., & Diwan, P. V.
(1998).
Pharmacodynamic and pharmacokinetic evaluation of lipid microspheres of indomethacin. Pharmaceutica acta Helvetiae.
73(4), 199-203.
-
Palakurthi, S. S., Shah, B., Kapre, S., Charbe, N., Immanuel, S., Pasham, S., ... Palakurthi, S.
A comprehensive review of challenges and advances in exosome-based drug delivery systems. NANOSCALE ADVANCES.
-
Srivatsa Palakurthi, S., Bharat Charbe, N., Recalde Phillips, S. Y., Alge, D. L., Lu, D., & Palakurthi, S.
(2023).
Development of optimal in vitro release and permeation testing method for rectal suppositories. 640, 123042-123042.
-
book
-
Bashir, S., Palakurthi, S., Zhou, H. C., & Liu, J.
(2014).
Nanometals and complexes in cancer diagnosis and therapy
-
Bashir, S., Palakurthi, S., Zhou, H. C., & Liu, J.
Handbook of Metallonutraceuticals. CRC Press.
-
Bashir, S., Palakurthi, S., Zhou, H. C., & Liu, J.
(2014).
Nanometals and complexes in cancer diagnosis and therapy
-
chapter
-
Bashir, S., Chava, S. R., Yuan, D., Palakurthi, S., & Liu, J.
(2020).
Metal-organic frameworks and exemplified cytotoxicity evaluation. METAL-ORGANIC FRAMEWORKS FOR BIOMEDICAL APPLICATIONS.
(pp. 347-381).
Elsevier.
-
Palakurthi, S., Yellepeddi, V. K., & Kumar, A.
(2011).
Nanocarriers for Cytosolic Drug and Gene Delivery in Cancer Therapy. Olsztynska, S., & Komorowska, M. (Eds.),
BIOMEDICAL ENGINEERING, TRENDS, RESEARCH AND TECHNOLOGIES.
(pp. 245-272).
IntechOpen.
-
Bashir, S., Chava, S. R., Yuan, D., Palakurthi, S., & Liu, J.
(2020).
Metal-organic frameworks and exemplified cytotoxicity evaluation. METAL-ORGANIC FRAMEWORKS FOR BIOMEDICAL APPLICATIONS.
(pp. 347-381).
Elsevier.
-
conference paper
-
Sharma, R., Venkatadri, R., Dogan, M., Palakurthi, S., Mohammad, S., Hudspeth, A., & Palakurthi, S
(2020).
Cationic Cyclodextrins Regulate Nucleic Acid-induced Proinflammatory Responses. Journal of Immunology.
-
Palakurthi, S., & Yellepeddi, V. K
(2014).
NANO POLYMER-CISPLATIN COMPLEXES FOR CHEMOTHERAPY OF OVARIAN CANCER. Anticancer Research: international journal of cancer research and treatment.
6095-6095.
-
Liu, J. L., Hernandez, E., Okakpu, U., Palakurthi, S., & Bashir, S
(2014).
Cytotoxicity evaluation of nanomaterials derived from green synthesis. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.
-
Hernandez, E., Posa, S. R., Du, X., Palakurthi, S., Liu, J., & Bashir, S
(2014).
Evaluation of design and magnetism of nanoparticles and their in vitro cytotoxicity analyses. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.
-
Martinez, B., Maganti, M., Palakurthi, S., Liu, J., & Bashir, S
(2014).
Functionalized metal-organic frameworks as inhibitor of cell division. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.
-
Wei, Z., Martinez, B., Zhou, H., Palakurthi, S., Bashir, S., & Liu, J.
(2014).
Investigation of nanostructured metal-organic frameworks used in cancer research. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.
-
Yellepeddi, V. K., Kumar, A., & Palakurthi, S
(2008).
BIOTINYLATED CISPLATIN-LOADED PAMAM DENDRIMERS FOR CHEMOTHERAPY OF OVARIAN CANCER. Anticancer Research: international journal of cancer research and treatment.
3432-3433.
-
Sharma, R., Venkatadri, R., Dogan, M., Palakurthi, S., Mohammad, S., Hudspeth, A., & Palakurthi, S
(2020).
Cationic Cyclodextrins Regulate Nucleic Acid-induced Proinflammatory Responses. Journal of Immunology.
Research
principal investigator on
investigator on
Teaching
teaching activities
- PHAR741 Pharmaceutics Ii Instructor
- PHAR785 Independent Study Instructor
- PHSC611 Drug Delvery & Formulations Instructor
- PHSC685 Directed Studies Instructor
- PHSC689 Sptp: Transderm & Topic Drug Instructor
- PHSC691 Research Instructor
Background
education and training
- Ph.D. in Pharmaceutics, Indian Institute of Chemical Technology - (Hyderabad, India) 2000
- Pharm.M. in Pharmaceutics, Dr. Hari Singh Gour University - (Saugor, Madhya Pradesh, India) 1993
- B.Pharm., Kakatiya University - (Warangal, India) 1991
awards and honors
Contact
first name
- Srinath
has last name
- Palakurthi
Other
- palakurthi@tamu.edu